Skip to main content
Text size:
 
 
 
 
InstantAtlas Server Logo
InstantAtlas™ Server 6
 
 
 
 
 
 
 
 
 
  Log In

InstantAtlas™ Server | Linked Data Portal

Resources | Summary List

 Resource: EAC(2012) Frailty Review

Summary description of Resource EAC(2012) Frailty Review. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/008feabd-d84d-469f-b31b-f09e6c8e5f45.

* Identifier 008feabd-d84d-469f-b31b-f09e6c8e5f45
* Label EAC(2012) Frailty Review
* Comment http://www.eac.cpft.nhs.uk/frailtyreview.aspx
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: CSAS(2011) Belimumab for the treatment of active autoantibody-positive systemic lupus erythematosus

Summary description of Resource CSAS(2011) Belimumab for the treatment of active autoantibody-positive systemic lupus erythematosus. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/8d494e60-0efe-4786-a0e7-847b584f4817.

* Identifier 8d494e60-0efe-4786-a0e7-847b584f4817
* Label CSAS(2011) Belimumab for the treatment of active autoantibody-positive systemic lupus erythematosus
* Comment http://www.sph.nhs.uk/appraisals/cs-appraisals-login-area/resources-to-support-pct-commissioning/rapid-evidence-reviews/belimumab-for-the-treatment-of-active-autoantibody-positive-systemic-lupus-erythematosus-1/at_download/file
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: CSAS(2010) Bevacizumab added to a taxane for the first-line treatment of metastatic breast cancer

Summary description of Resource CSAS(2010) Bevacizumab added to a taxane for the first-line treatment of metastatic breast cancer. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/a46956be-228e-4c5f-a5d4-99936a1a2fbd.

* Identifier a46956be-228e-4c5f-a5d4-99936a1a2fbd
* Label CSAS(2010) Bevacizumab added to a taxane for the first-line treatment of metastatic breast cancer
* Comment http://www.sph.nhs.uk/appraisals/cs-appraisals-login-area/resources-to-support-pct-commissioning/rapid-evidence-reviews/BevacizumabForBreastCancer_RapidEvidenceReview_2010_February.pdf/at_download/file
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: CSAS(2011) Bevacizumab for the first-line treatment of ovarian cancer

Summary description of Resource CSAS(2011) Bevacizumab for the first-line treatment of ovarian cancer . Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/5d8b77fe-0103-4282-aa0e-5960ad66c4dc.

* Identifier 5d8b77fe-0103-4282-aa0e-5960ad66c4dc
* Label CSAS(2011) Bevacizumab for the first-line treatment of ovarian cancer
* Comment http://www.sph.nhs.uk/appraisals/cs-appraisals-login-area/resources-to-support-pct-commissioning/rapid-evidence-reviews/bevacizumab-for-the-first-line-treatment-of-ovarian-cancer/at_download/file
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: CSAS(2011) Bevacizumab in combination with paclitaxel and carboplatin for advanced and or metastatic ovarian cancer

Summary description of Resource CSAS(2011) Bevacizumab in combination with paclitaxel and carboplatin for advanced and or metastatic ovarian cancer . Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/b686311d-d50e-43ae-81f3-e2636f8a5453.

* Identifier b686311d-d50e-43ae-81f3-e2636f8a5453
* Label CSAS(2011) Bevacizumab in combination with paclitaxel and carboplatin for advanced and or metastatic ovarian cancer
* Comment http://www.sph.nhs.uk/appraisals/cs-appraisals-login-area/resources-to-support-pct-commissioning/rapid-evidence-reviews/bevacizumab-in-combination-with-paclitaxel-and-carboplatin-for-advanced-andor-metastatic-ovarian-cance/at_download/file
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: CSAS(2011) Bivalirudin for the treatment of ST-segment elevation myocardial infarction

Summary description of Resource CSAS(2011) Bivalirudin for the treatment of ST-segment elevation myocardial infarction. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/52563e3c-c8ad-4571-94c0-2e83e70da9e2.

* Identifier 52563e3c-c8ad-4571-94c0-2e83e70da9e2
* Label CSAS(2011) Bivalirudin for the treatment of ST-segment elevation myocardial infarction
* Comment http://www.sph.nhs.uk/appraisals/cs-appraisals-login-area/resources-to-support-pct-commissioning/rapid-evidence-reviews/bivalirudin-for-the-treatment-of-st-segment-elevation-myocardial-infarction/at_download/file
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: CSAS(2011) Cabazitaxel for metastatic prostate cancer

Summary description of Resource CSAS(2011) Cabazitaxel for metastatic prostate cancer. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/a2b7754e-67b6-4c4b-8bbc-6e107e0b272b.

* Identifier a2b7754e-67b6-4c4b-8bbc-6e107e0b272b
* Label CSAS(2011) Cabazitaxel for metastatic prostate cancer
* Comment http://www.sph.nhs.uk/appraisals/cs-appraisals-login-area/resources-to-support-pct-commissioning/rapid-evidence-reviews/cabazitaxel-for-metastatic-prostate-cancer/at_download/file
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: CSAS(2010) Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease

Summary description of Resource CSAS(2010) Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/416752ea-916b-431c-8c88-3138a3815568.

* Identifier 416752ea-916b-431c-8c88-3138a3815568
* Label CSAS(2010) Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease
* Comment http://www.sph.nhs.uk/appraisals/cs-appraisals-login-area/resources-to-support-pct-commissioning/rapid-evidence-reviews/Cilostazol_IntermittentClaudicationPAD_RapidEvidenceReview_2010_June.pdf/at_download/file
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: CSAS(2010) Cladribine for the treatment of relapsing-remitting multiple sclerosis

Summary description of Resource CSAS(2010) Cladribine for the treatment of relapsing-remitting multiple sclerosis. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/2c8fd58d-6298-4c98-91f1-d86f7cbf0fe5.

* Identifier 2c8fd58d-6298-4c98-91f1-d86f7cbf0fe5
* Label CSAS(2010) Cladribine for the treatment of relapsing-remitting multiple sclerosis
* Comment http://www.sph.nhs.uk/appraisals/cs-appraisals-login-area/resources-to-support-pct-commissioning/rapid-evidence-reviews/Cladribine_RapidEvidenceReview_2010_April.pdf/at_download/file
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: Kirklees Evidence Review (2011): Sativex to provide pain relief for pain or spasm associated with major surgery

Summary description of Resource Kirklees Evidence Review (2011): Sativex to provide pain relief for pain or spasm associated with major surgery. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/36283393-8474-47C1-9D48-A7B610966E6F.

* Identifier 36283393-8474-47C1-9D48-A7B610966E6F
* Label Kirklees Evidence Review (2011): Sativex to provide pain relief for pain or spasm associated with major surgery
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: Kirklees Evidence Review (2011): Affect of Obesity on knee hip replacements review

Summary description of Resource Kirklees Evidence Review (2011): Affect of Obesity on knee hip replacements review. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/E666DD15-3D33-4D02-87D7-94B8296F1EDF.

* Identifier E666DD15-3D33-4D02-87D7-94B8296F1EDF
* Label Kirklees Evidence Review (2011): Affect of Obesity on knee hip replacements review
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: Kirklees Evidence Review (2011): Primary repair of inguinal hernia by insert of prosthetic material review

Summary description of Resource Kirklees Evidence Review (2011): Primary repair of inguinal hernia by insert of prosthetic material review. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/C9DEDA7C-1EAA-42AA-B278-BCE4863AF6B6.

* Identifier C9DEDA7C-1EAA-42AA-B278-BCE4863AF6B6
* Label Kirklees Evidence Review (2011): Primary repair of inguinal hernia by insert of prosthetic material review
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: CSAS(2010) Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation

Summary description of Resource CSAS(2010) Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/5f535ce8-4372-4c66-be2f-1cf2e7fc180e.

* Identifier 5f535ce8-4372-4c66-be2f-1cf2e7fc180e
* Label CSAS(2010) Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation
* Comment http://www.sph.nhs.uk/appraisals/cs-appraisals-login-area/resources-to-support-pct-commissioning/rapid-evidence-reviews/dabigatran-etexilate-for-the-prevention-of-stroke-and-systemic-embolism-in-atrial-fibrillation/at_download/file
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: CSAS(2010) Dasatinib, high dose imatinib and nilotinib for the treatment of chronic myeloid leukaemia

Summary description of Resource CSAS(2010) Dasatinib, high dose imatinib and nilotinib for the treatment of chronic myeloid leukaemia. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/405a3113-36a7-4fc2-9f42-38b1612726bd.

* Identifier 405a3113-36a7-4fc2-9f42-38b1612726bd
* Label CSAS(2010) Dasatinib, high dose imatinib and nilotinib for the treatment of chronic myeloid leukaemia
* Comment http://www.sph.nhs.uk/appraisals/cs-appraisals-login-area/resources-to-support-pct-commissioning/rapid-evidence-reviews/dasatinib-high-dose-imatinib-and-nilotinib-for-the-treatment-of-chronic-myeloid-leukaemia/at_download/file
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: CSAS(2010) Denosumab for the prevention of osteoporotic fractures in postmenopausal women

Summary description of Resource CSAS(2010) Denosumab for the prevention of osteoporotic fractures in postmenopausal women. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/92f79370-619d-45fa-a027-8786a64760fb.

* Identifier 92f79370-619d-45fa-a027-8786a64760fb
* Label CSAS(2010) Denosumab for the prevention of osteoporotic fractures in postmenopausal women
* Comment http://www.sph.nhs.uk/appraisals/cs-appraisals-login-area/resources-to-support-pct-commissioning/rapid-evidence-reviews/Denosumab_RapidEvidenceReview_2010_January_Final.pdf/at_download/file
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: CSAS(2011) Desferrioxamine deferiprone and deferasirox for the treatment of chronic iron overload in people with thalassaemia

Summary description of Resource CSAS(2011) Desferrioxamine deferiprone and deferasirox for the treatment of chronic iron overload in people with thalassaemia. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/5591fcce-cc81-4706-be24-52c6ffd58e37.

* Identifier 5591fcce-cc81-4706-be24-52c6ffd58e37
* Label CSAS(2011) Desferrioxamine deferiprone and deferasirox for the treatment of chronic iron overload in people with thalassaemia
* Comment http://www.sph.nhs.uk/appraisals/cs-appraisals-login-area/resources-to-support-pct-commissioning/rapid-evidence-reviews/desferrioxamine-deferiprone-and-deferasirox-for-the-treatment-of-chronic-iron-overload-in-people-with-thalassaemia/at_download/file
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: CSAS(2010) Dexamethasone intravitreal implant for the treatment of macular oedema caused by retinal vein occlusion

Summary description of Resource CSAS(2010) Dexamethasone intravitreal implant for the treatment of macular oedema caused by retinal vein occlusion. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/ab300f01-285e-46bc-ba30-a6333e28db1c.

* Identifier ab300f01-285e-46bc-ba30-a6333e28db1c
* Label CSAS(2010) Dexamethasone intravitreal implant for the treatment of macular oedema caused by retinal vein occlusion
* Comment http://www.sph.nhs.uk/appraisals/cs-appraisals-login-area/resources-to-support-pct-commissioning/rapid-evidence-reviews/DexamethasoneMacularOedema_RapidEvidenceReview_2010_September.pdf/at_download/file
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: National End of Life Care Profiles [Link]

Summary description of Resource National End of Life Care Profiles [Link]. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/fa8929a0-dc1f-4087-aa59-3a482b48e2c3.

* Identifier fa8929a0-dc1f-4087-aa59-3a482b48e2c3
* Label National End of Life Care Profiles [Link]
* Comment http://www.endoflifecare-intelligence.org.uk/profiles.aspx
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: INVOLVE - Information about consultation in Kirklees

Summary description of Resource INVOLVE - Information about consultation in Kirklees. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/b0f0bd82-6c04-44bf-949f-c49a9dfe7d07.

* Identifier b0f0bd82-6c04-44bf-949f-c49a9dfe7d07
* Label INVOLVE - Information about consultation in Kirklees
* Comment https://www.kirklees.gov.uk/involve/
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: Office for National Statistics Home Page

Summary description of Resource Office for National Statistics Home Page. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/3e1aecb6-1332-4f16-8a87-b16e928c97d6.

* Identifier 3e1aecb6-1332-4f16-8a87-b16e928c97d6
* Label Office for National Statistics Home Page
* Comment http://www.ons.gov.uk/ons/index.html
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: The 2011 Census

Summary description of Resource The 2011 Census. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/5d0c2987-8929-4cb4-b9ab-762b792ac9aa.

* Identifier 5d0c2987-8929-4cb4-b9ab-762b792ac9aa
* Label The 2011 Census
* Comment http://www.ons.gov.uk/ons/guide-method/census/2011/index.html
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: Research Councils

Summary description of Resource Research Councils. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/26aca061-2a87-42ff-9679-c80b134201f5.

* Identifier 26aca061-2a87-42ff-9679-c80b134201f5
* Label Research Councils
* Comment http://www.rcuk.ac.uk/pages/home.aspx
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: Josef Rowntree Foundation

Summary description of Resource Josef Rowntree Foundation. Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/6664fc36-8509-42d1-a267-ce5df842f599.

* Identifier 6664fc36-8509-42d1-a267-ce5df842f599
* Label Josef Rowntree Foundation
* Comment http://www.jrf.org.uk/
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: Projecting Adults Needs and Service Information (PANSI)

Summary description of Resource Projecting Adults Needs and Service Information (PANSI). Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/6bbd34b3-8ee5-4dc8-8288-bd9d5070b228.

* Identifier 6bbd34b3-8ee5-4dc8-8288-bd9d5070b228
* Label Projecting Adults Needs and Service Information (PANSI)
* Comment http://www.pansi.org.uk/
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

 Resource: Projecting Older People Population Information (POPPI)

Summary description of Resource Projecting Older People Population Information (POPPI). Additional details (and access to the data) are available here: https://observatory.kirklees.gov.uk/linked-data/id/resource/4ffa9222-a360-4fd4-aa0a-4fd3ae1bbcec.

* Identifier 4ffa9222-a360-4fd4-aa0a-4fd3ae1bbcec
* Label Projecting Older People Population Information (POPPI)
* Comment http://www.poppi.org.uk/
* Type Resource
* Dublin Core Type http://purl.org/dc/dcmitype/InteractiveResource

Alternate formats of this page · RDF · HTML · JSON ·

 
 ·  Accessibility  ·  Site Map  ·  Contact Us  ·  Legal  ·  Feedback  ·  About  ·